ERIC Number: EJ1179522
Record Type: Journal
Publication Date: 2018-May
Abstractor: As Provided
Prenatal Opioid and Alcohol Exposure: Understanding Neonatal Abstinence Syndrome and Fetal Alcohol Spectrum Disorders to Safeguard Maternal and Child Outcomes
Rodríguez, Jennifer J.; Smith, Vincent C.
ZERO TO THREE, v38 n5 p23-28 May 2018
Substance use and alcohol abuse during pregnancy are significant public health concerns. Neonatal abstinence syndrome (NAS) is a withdrawal syndrome that infants exposed to opioids may experience in the first few days of life. For most infants with NAS, exposure to opioids occurs during pregnancy while they are fetuses. Similarly, prenatal alcohol exposure (PAE) is the most common preventable cause of intellectual and developmental delay and disabilities in the United States. Fetal alcohol spectrum disorders (FASDs) is a term used to describe preventable birth defects and intellectual/developmental disabilities resulting from PAE. This article offers a general overview of NAS assessment, management, and treatment considerations, as well as a brief overview of FASD.
Descriptors: Prenatal Influences, Neonates, Drug Use, Alcohol Abuse, Pregnancy, Public Health, Prevention, Fetal Alcohol Syndrome, Developmental Delays, Drug Rehabilitation, Clinical Diagnosis, Mothers, Epidemiology, Premature Infants, Drug Abuse, Intervention, Perinatal Influences, Safety, Addictive Behavior, Therapy
ZERO TO THREE. 1255 23rd Street NW Suite 350, Washington, DC 20037. Tel: 800-899-4301; Tel: 202-638-1144; Fax: 202-638-0851; Web site: http://zerotothree.org/
Publication Type: Journal Articles; Reports - Descriptive
Education Level: N/A
Authoring Institution: N/A
Grant or Contract Numbers: N/A